Your browser doesn't support javascript.
loading
European value-based healthcare benchmarking: moving from theory to practice.
García-Lorenzo, Borja; Gorostiza, Ania; Alayo, Itxaso; Castelo Zas, Susana; Cobos Baena, Patricia; Gallego Camiña, Inés; Izaguirre Narbaiza, Begoña; Mallabiabarrena, Gaizka; Ustarroz-Aguirre, Iker; Rigabert, Alina; Balzi, William; Maltoni, Roberta; Massa, Ilaria; Álvarez López, Isabel; Arévalo Lobera, Sara; Esteban, Mónica; Fernández Calleja, Marta; Gómez Mediavilla, Jenifer; Fernández, Manuela; Del Oro Hitar, Manuel; Ortega Torres, María Del Carmen; Sanz Ferrandez, María Consuelo; Manso Sánchez, Luís; Serrano Balazote, Pablo; Varela Rodríguez, Carolina; Campone, Mario; Le Lann, Sophie; Vercauter, Piet; Tournoy, Kurt; Borges, Marina; Oliveira, Ana Sofía; Soares, Marta; Fullaondo, Ane.
Affiliation
  • García-Lorenzo B; Biosistemak Institute for Health Systems Research, Torre del Bilbao Exhibition Centre, Barakaldo, Spain.
  • Gorostiza A; Biosistemak Institute for Health Systems Research, Torre del Bilbao Exhibition Centre, Barakaldo, Spain.
  • Alayo I; Biosistemak Institute for Health Systems Research, Torre del Bilbao Exhibition Centre, Barakaldo, Spain.
  • Castelo Zas S; Osakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Innovation and Quality Assistant Service, Barakaldo-Bizkaia, Spain.
  • Cobos Baena P; Osakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Mammary Pathology Service, Barakaldo-Bizkaia, Spain.
  • Gallego Camiña I; Osakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Innovation and Quality Assistant Service, Barakaldo-Bizkaia, Spain.
  • Izaguirre Narbaiza B; Osakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Analytical Accounting, Economic and Financial Directorate, Barakaldo, Spain.
  • Mallabiabarrena G; Osakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Mammary Pathology Service, Barakaldo-Bizkaia, Spain.
  • Ustarroz-Aguirre I; Osakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Economic Evaluation Unit, Economic and Financial Directorate, Barakaldo, Spain.
  • Rigabert A; Fundación Andaluza Beturia para la Investigación en Salud (FABIS), Huelva, Spain.
  • Balzi W; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Maltoni R; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Massa I; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Álvarez López I; Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Medical Oncology, Donostia, Spain.
  • Arévalo Lobera S; Biodonostia, Donostia, Gipuzkoa, Spain.
  • Esteban M; Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Medical Oncology, Donostia, Spain.
  • Fernández Calleja M; Biodonostia, Donostia, Gipuzkoa, Spain.
  • Gómez Mediavilla J; Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Economic Resource Service, Donostia, Gipuzkoa, Spain.
  • Fernández M; Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Mamary Pathology Service, Donostia, Gipuzkoa, Spain.
  • Del Oro Hitar M; Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Medical Oncology, Donostia, Spain.
  • Ortega Torres MDC; Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Economic Resource Service, Donostia, Gipuzkoa, Spain.
  • Sanz Ferrandez MC; Gynecology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Manso Sánchez L; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Serrano Balazote P; Gynecology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Varela Rodríguez C; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Campone M; Gynecology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Le Lann S; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Vercauter P; Instituto de Investigación Biomédica del Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Tournoy K; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Borges M; Instituto de Investigación Biomédica del Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Oliveira AS; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Soares M; Instituto de Investigación Biomédica del Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Fullaondo A; Institut de Cancérologie de l'Ouest, Angers-Nantes, France.
Eur J Public Health ; 34(1): 44-51, 2024 Feb 05.
Article in En | MEDLINE | ID: mdl-37875008
ABSTRACT

BACKGROUND:

Value-based healthcare (VBHC) is a conceptual framework to improve the value of healthcare by health, care-process and economic outcomes. Benchmarking should provide useful information to identify best practices and therefore a good instrument to improve quality across healthcare organizations. This paper aims to provide a proof-of-concept of the feasibility of an international VBHC benchmarking in breast cancer, with the ultimate aim of being used to share best practices with a data-driven approach among healthcare organizations from different health systems.

METHODS:

In the VOICE community-a European healthcare centre cluster intending to address VBHC from theory to practice-information on patient-reported, clinical-related, care-process-related and economic-related outcomes were collected. Patient archetypes were identified using clustering techniques and an indicator set following a modified Delphi was defined. Benchmarking was performed using regression models controlling for patient archetypes and socio-demographic characteristics.

RESULTS:

Six hundred and ninety patients from six healthcare centres were included. A set of 50 health, care-process and economic indicators was distilled for benchmarking. Statistically significant differences across sites have been found in most health outcomes, half of the care-process indicators, and all economic indicators, allowing for identifying the best and worst performers.

CONCLUSIONS:

To the best of our knowledge, this is the first international experience providing evidence to be used with VBHC benchmarking intention. Differences in indicators across healthcare centres should be used to identify best practices and improve healthcare quality following further research. Applied methods might help to move forward with VBHC benchmarking in other medical conditions.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Health Care / Benchmarking Limits: Humans Language: En Journal: Eur J Public Health Journal subject: EPIDEMIOLOGIA / SAUDE PUBLICA Year: 2024 Document type: Article Affiliation country: España

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Health Care / Benchmarking Limits: Humans Language: En Journal: Eur J Public Health Journal subject: EPIDEMIOLOGIA / SAUDE PUBLICA Year: 2024 Document type: Article Affiliation country: España